Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF6001 DPI allergen-challenge crossover study in adult asthma
2012-001483-29Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tanimilast in asthma and allergic asthma (3 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Late asthmatic response. Started Jun 2012; status: completed.
02
Drugs
tanimilast
03
Conditions
asthmaallergic asthma
Beyond the preview
Go deeper on 2012-001483-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001483-29.